We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

72 hedge funds and large institutions have $203M invested in ChemoCentryx, Inc. in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

29% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 17

25% more capital invested

Capital invested by funds: $163M → $203M (+$40M)

11% more funds holding

Funds holding: 6572 (+7)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

52% less call options, than puts

Call options by funds: $293K | Put options by funds: $615K

Holders
72
Holders Change
+7
Holders Change %
+10.77%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
11
Increased
22
Reduced
17
Closed
4
Calls
$293K
Puts
$615K
Net Calls
-$322K
Net Calls Change
-$425K
Name Holding Trade Value Shares
Change
Change in
Stake
RG
26
Redmile Group
California
$512K -$3.1M -437,426 -87%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$509K
Parallax Volatility Advisers
28
Parallax Volatility Advisers
California
$491K +$429K +60,557 New
Deutsche Bank
29
Deutsche Bank
Germany
$467K -$221K -31,271 -35%
BPC
30
Banque Pictet & Cie
Switzerland
$439K
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$420K +$6.96K +984 +2%
BCM
32
Bridgeway Capital Management
Texas
$405K
BBA
33
Baker Bros. Advisors
New York
$397K
Renaissance Technologies
34
Renaissance Technologies
New York
$359K +$139K +19,600 +79%
TA
35
Teachers Advisors
New York
$331K
Bank of America
36
Bank of America
North Carolina
$323K +$216K +30,452 +324%
ProShare Advisors
37
ProShare Advisors
Maryland
$320K +$23.2K +3,278 +9%
Citadel Advisors
38
Citadel Advisors
Florida
$316K +$277K +39,101 New
KeyBank National Association
39
KeyBank National Association
Ohio
$311K
Charles Schwab
40
Charles Schwab
California
$284K
RA
41
Royce & Associates
New York
$270K -$154K -21,700 -39%
Two Sigma Investments
42
Two Sigma Investments
New York
$264K +$230K +32,537 New
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$232K +$15K +2,120 +8%
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$207K
MLICM
45
Metropolitan Life Insurance Company (MetLife)
New York
$184K +$161K +22,688 New
DekaBank Deutsche Girozentrale
46
DekaBank Deutsche Girozentrale
Germany
$182K +$3.54K +500 +2%
PBT
47
Pictet Bank & Trust
Bahamas
$170K
Creative Planning
48
Creative Planning
Kansas
$163K +$84.9K +12,000 +147%
Goldman Sachs
49
Goldman Sachs
New York
$157K +$17.4K +2,463 +15%
Point72 Asset Management
50
Point72 Asset Management
Connecticut
$157K +$137K +19,400 New

CCXI Hedge Fund Activity: Q4 2015 in Review

72 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2015, worth a combined $203M — up 25% from $163M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CCXI positions and 4 closed out — a net gain of 7 holders — while 22 added to existing stakes and 17 trimmed.

The largest buyer was Credit Suisse, adding an estimated $2.69M. The largest seller was BVF Inc, cutting an estimated $6.34M.

  • 72 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2015, up from 65 in Q3 2015.
  • Funds reported $203M of ChemoCentryx, Inc. stock for Q4 2015, up 25% quarter-over-quarter.
  • 11 funds opened new ChemoCentryx, Inc. positions in Q4 2015 and 4 closed out, a net change of +7 holders.
  • The largest ChemoCentryx, Inc. buyer in Q4 2015 was Credit Suisse, an estimated $2.69M added.
  • The largest ChemoCentryx, Inc. seller in Q4 2015 was BVF Inc, an estimated $6.34M sold.

Based on aggregated 13F filings for Q4 2015.